Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

United Healthcare Is an Obamacare Opportunity

By Dana Blankenhorn, InvestorPlace Contributor

UNH stock did extremely well in the Obamacare era and is well positioned for whatever comes next in the sector.

Cloud Stocks Rely on the Software Stack

By Dana Blankenhorn, InvestorPlace Contributor

Opponents of major cloud companies are now using courts, political pressure and even geopolitics to destroy these tech stocks' cash flow.

7 5G Stocks for the Next Communication Revolution

By Dana Blankenhorn, InvestorPlace Contributor

5G isn't about video or phones. It's about the Machine Internet. And the market is in its early days, meaning there is plenty of time to profit.

CVS Health and the Managed Care Strategy

By Dana Blankenhorn, InvestorPlace Contributor

CVS is working to position itself for the era of managed care, with low-cost pharmacies and clinics. But will that era arrive?

Novavax Investors Betting They Have the COVID-19 Solution

By Dana Blankenhorn, InvestorPlace Contributor

Novavax has gotten $2 billion in support from the government, and is rushing its COVID-19 vaccine candidate through trials, hoping its adjuvant makes for fast distribution.

TerraCycle CEO Creates a Likely Crowdfund Unicorn

By Dana Blankenhorn, InvestorPlace Contributor

TerraCycle has developed scalable solutions for recycling plastic we now throw in the garbage, along with a compelling business model.

Nokia: OpenRAN Opens Radio’s Pandora’s Box

By Dana Blankenhorn, InvestorPlace Contributor

Open technologies are coming to mobile infrastructure, but possibly in the hands of the cloud czars, which could crush Nokia like a bug.

Ericsson Wants to be the Carriers’ Qualcomm in 5G Race

By Dana Blankenhorn, InvestorPlace Contributor

ERIC stock holders should watch for merger talks as Ericsson executives contend with the Cloud Czars who favor open 5G systems.

Don’t Buy iBio Stock for a Coronavirus Vaccine

By Dana Blankenhorn, InvestorPlace Contributor

Speculators chased IBIO stock up in hopes of a coronavirus vaccine, but long-term investors should stay far away from iBio here.

Comcast Bets a Cable Monopoly Can Be a Phone Company

By Dana Blankenhorn, InvestorPlace Contributor

Comcast is trying to maintain its position as a dominant company in the Internet's last mile. Here's how it affects Comcast stock.

Load More